CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.
about
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will playBiological markers of amyloid beta-related mechanisms in Alzheimer's diseaseZinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluidBiomarkers of Alzheimer's diseaseA/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkersFluid Biomarkers in Clinical Trials of Alzheimer's Disease TherapeuticsAutosomal Dominant Alzheimer Disease: A Unique Resource to Study CSF Biomarker Changes in Preclinical ADBiological markers of Alzheimer's diseaseNew pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugsCerebrospinal fluid and blood biomarkers in Alzheimer's diseaseHarnessing Cerebrospinal Fluid Biomarkers in Clinical Trials for Treating Alzheimer's and Parkinson's Diseases: Potential and ChallengesBeta-amyloid deposition and the aging brainCerebrospinal Fluid Biomarkers for Alzheimer's Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker TeamGenome-wide association study of the rate of cognitive decline in Alzheimer's disease.GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascadeTracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkersBiomarkers in amyloid-β immunotherapy trials in Alzheimer's disease.CSF biomarkers for mild cognitive impairment.[Neurobiological early diagnosis of Alzheimer's disease]Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide.Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease.Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.Quantitative structural MRI for early detection of Alzheimer's disease.Brain changes in older adults at very low risk for Alzheimer's disease.Multicenter Analytical Validation of Aβ40 Immunoassays.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Reduced CSF turnover and decreased ventricular Aβ42 levels are relatedEffect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer diseaseSoluble amyloid-β levels and late-life depressionCerebrospinal fluid analysis should be considered in patients with cognitive problemsLessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease.Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's diseaseThe diagnosis and evaluation of dementia and mild cognitive impairment with emphasis on SPECT perfusion neuroimaging.CSF and plasma amyloid-β temporal profiles and relationships with neurological status and mortality after severe traumatic brain injuryBiomarkers and cognitive endpoints to optimize trials in Alzheimer's disease.
P2860
Q21202832-6186600C-0A35-4665-9574-2D9DB1B274C4Q24594531-DC3B2C94-A0B6-4B9F-8450-A567CBBC769AQ24622136-0BD3A6F7-0F84-4B78-AF59-9242C462E8E9Q24649556-0D627974-B171-445B-B59F-B57ABCFBAAB3Q24650667-70311F6E-5B41-4470-8F92-175C23480F02Q26745508-C27E19C2-AAB6-4203-97BB-14F2C3492233Q26784569-75A76647-FB63-42C2-A88F-D6054F839E23Q26801666-194381FA-A377-433F-88B9-2654CBEBD883Q26823847-553EE0E6-E8DF-4013-8E85-800433345A47Q26866006-28D7942B-E89A-4F34-B475-D8CB6541F7BBQ27023758-4B83D26A-D129-4420-8932-88AE2377FDBBQ28072061-0311E485-A7DC-4834-9D76-B5218CC5280AQ28264556-FA6E1E87-5FA9-4A36-8B93-19A5FE668A1EQ28595520-0BB1A0C3-AAC2-492B-8955-374965A95DF8Q29416991-9FEA344B-4DBE-49FB-86D5-D678619DDCC3Q29417137-32B388DE-1423-4B84-8E79-FF4F83F57892Q29614407-405EAE4B-922C-4852-81E4-4E63A0BE0358Q29620245-3A444B58-84CE-40B1-9C91-92D7AE232D35Q30651551-B19C6E8F-FD29-44C8-BC3A-FC82F5B1E185Q30953185-505C4986-33C3-4782-A37E-661C759A8479Q31117740-E56E4B8D-41F9-42B2-902B-1765D3CDB637Q33515877-85AA4032-6B5C-47C4-9FC0-B2F8A3F07ABEQ33520347-05A90BAF-ACD8-4656-B2AC-97BD092916FFQ33638748-5529EAEC-699D-4707-B1BD-9C7A6E852418Q33687554-DAFFC541-F7DF-426A-B24C-B4DB0216741CQ33729033-E2C52938-D6DE-4DFF-9D25-F35275C3BD68Q33729050-6051659D-42CF-4949-A2E5-035EA7B4BAC6Q33871427-A7ABEED8-FF53-4FD5-BE41-5A89174D9944Q33881726-A60F1108-643B-4ABC-85D4-642EF4F232F0Q33898968-82BCB5FE-E72B-4891-B5BB-ACFBF3B083AFQ33917722-D4745A82-0E24-4A14-8473-2C4D818CE207Q33933220-77BD4CC7-5339-4557-8D7D-D9BE9B188D51Q34026659-46010D9F-3B4E-4940-9C96-D0451776885EQ34043074-11D91603-3734-45C1-8366-8ADA4ABAAE95Q34098866-1AC175C0-C408-45D5-B1F4-C3E2EE6F228DQ34222721-D0D2388D-76B0-433B-847F-BE3BB5510476Q34247849-F7141EB2-A51B-4738-BEDB-B8DEBECAFA5FQ34296479-03442F77-7BD8-4875-967B-1B6D518A3A9BQ34318048-D577830F-2BFE-4665-AEE4-5AB572DEF9B9Q34477459-7078B9E2-D97E-4704-8501-8387769A420D
P2860
CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@en
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@nl
type
label
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@en
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@nl
prefLabel
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@en
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@nl
P2093
P1433
P1476
CSF Abeta 42 levels correlate ...... opulation-based autopsy study.
@en
P2093
P304
P356
10.1212/01.WNL.0000046581.81650.D0
P407
P577
2003-02-01T00:00:00Z